Received: 9 April 2020
Accepted: 30 July 2020
First Online: 6 August 2020
Ethics approval and consent to participate
: Enrollment of the patient in a clinical trial was completed in compliance with our institution’s ethics committee and institutional review board.
: Consent for publication was obtained from the patient using our institution’s consent policy and will be provided upon request.
: AC receives research funding from Ignyta and Genentech for the conduct of the entrectinib study, and provides consulting for Genentech and scientific advisement for Deciphera; no other authors have competing interests to declare.